Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Churg-Strauss syndrome successfully treated with rituximab
Rheumatology International, 10/15/09
Donvik KK et al. – Churg–Strauss syndrome (CSS) is characterized by small–vessel vasculitis, extravascular granulomatous inflammation, and massive eosinophilia in tissues and blood, and is often accompanied by a history of preclinical asthma and/or allergic rhinitis lasting several years before the syndrome develops its full clinical picture. The authors describe two patients resistant to conventional therapy who were treated with rituximab and experienced a rapid and substantial decrease in disease activity and asthmatic symptoms and an increase in physical capacity.
Related Articles
Churg-Strauss syndrome: evidence for disease subtypes?
Current Opinion in Rheumatology, 10/26/09
Relevance Score: 67%
Therapeutic Angiogenesis by Controlled-Release Fibroblast Growth Factor in a Patient With Churg-Strauss Syndrome Complicated by an Intractable Ischemic Leg Ulcer
The American Journal of the Medical Sciences, 10/20/09
Relevance Score: 67%
Recent progress in the genetics of Wegeners granulomatosis and Churg-Strauss syndrome
Current Opinion in Rheumatology, 10/30/09
Relevance Score: 64%
Successful Treatment With Sumatriptan in a Case With Cyclic Vomiting Syndrome Combined With 18q– Syndrome
Journal of Child Neurology, 10/02/09
Relevance Score: 47%
Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09
Relevance Score: 46%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Measuring Attractiveness for Abuse of Prescription Opioids
Pain Medicine, 11/29/09
Estimating Attractiveness for Abuse of a Not-Yet-Marketed "Abuse-Deterrent" Prescription Opioid Formulation
Pain Medicine, 11/29/09
Age and Sex Trends in Long-Term Opioid Use in Two Large American Health Systems Between 2000 and 2005
Pain Medicine, 11/29/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Biomarkers as tools for improved diagnostic and therapeutic monitoring in SLE
Arthritis Research & Therapy, 11/25/09
A survey on the management of gout in Malaysia
International Journal of Rheumatic Diseases, 11/25/09
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis
International Journal of Rheumatic Diseases, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


